
Please try another search
Ananda Pharma Plc, together with its subsidiaries, invests in the medicinal and therapeutic cannabis market in the United Kingdom and internationally. The company provides cannabinoid-based medicines for the treatment of chronic inflammatory pain conditions. It also grows melon and root tubers; develops and distributes health products; wholesales pharmaceutical goods; manufactures and sells organic basic and essential oils; and is involved in crop production activities. The company was formerly known as Ananda Developments Plc and changed its name to Ananda Pharma Plc in December 2024. Ananda Pharma Plc was incorporated in 2018 and is based in London, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Jeremy Edward Sturgess-Smith | 29 | 2023 | Finance Director & Executive Director |
John Michael Treacy | 43 | 2018 | Independent Non-Executive Director |
Melissa Josephine Sturgess | 58 | 2018 | CEO & Director |
Stuart William Piccaver | 53 | 2022 | Non-Executive Director |
Marie Fallon | - | 2024 | Member of Scientific Advisory Board |
Clive P. Page | 66 | 2023 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review